In the absence of AD (due to the inability of AβPP-derived iAβ to reach the AD pathology-causing levels) in transgenic mice overexpressing human AβPP, this is the only plausible explanation for the observed neurodegeneration. The gene discussed is APP; the disease is Alzheimer disease.